Opiant Pharmaceuticals OverviewOpiant Pharmaceuticals Net Income
Profitability analysis for OPNT.
Quarterly Net Income
-$9.92M
↓ 390.21% YoY
As of Sep 2022
Annual Net Income (TTM)
-$33.49M
↓ 2231.83% YoY
Trailing 12 months ending Sep 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...